Penn Medicine Penn Hypertension, Insulin Resistance, Lipid, and Atherosclerosis Meeting 2025
$15.00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
-
Penn Medicine Hypertension, Insulin Resistance, Lipid, and Atherosclerosis Meeting 2025
Advanced Preventive Cardiology and Cardiometabolic Medicine Update
Overview
The Penn Medicine Hypertension, Insulin Resistance, Lipid, and Atherosclerosis Meeting 2025 is a comprehensive cardiovascular prevention program focused on the evolving management of hypertension, insulin resistance, dyslipidemia, chronic kidney disease (CKD), and atherosclerotic cardiovascular disease (ASCVD).
Presented by experts from Penn Medicine, this virtual conference delivers evidence-based updates on the latest pharmacologic therapies, risk reduction strategies, and preventive cardiology approaches aimed at reducing cardiovascular morbidity and mortality.
Cardiovascular disease remains the leading cause of death worldwide, and major risk factors such as hypertension, diabetes, insulin resistance, hyperlipidemia, obesity, and CKD continue to drive the burden of heart attacks, strokes, peripheral artery disease, and heart failure. This course explores the underlying pathophysiology of cardiometabolic disease and reviews contemporary approaches to prevention and treatment.
Participants will gain practical guidance on applying current guidelines, incorporating emerging therapies, and improving cardiovascular outcomes in high-risk populations.
Course Specifications
Format
- 18 Video Lectures
- 17 PDF Presentations
Total Size
- 1.5 GB
Date
September 19, 2025
Location
Virtual Conference
Educational Level
Intermediate to Advanced
Specialty
Preventive Cardiology & Cardiometabolic Medicine
Learning Objectives
Upon completion of this activity, participants should be able to:
- Select evidence-based therapies that reduce cardiovascular risk.
- Apply contemporary hypertension management strategies.
- Optimize treatment of dyslipidemia and atherosclerotic disease.
- Understand the cardiovascular benefits of emerging metabolic therapies.
- Evaluate controversies in cardiovascular disease prevention.
- Identify appropriate screening strategies for hypertension and cardiovascular risk.
- Integrate CKD management into cardiovascular prevention programs.
- Implement lifestyle and pharmacologic approaches to reduce ASCVD risk.
- Improve outcomes in high-risk and vulnerable patient populations.
Core Topics Covered
Hypertension Management
Comprehensive updates on blood pressure control and cardiovascular risk reduction.
Topics Include
- Contemporary Hypertension Guidelines
- Resistant Hypertension
- Ambulatory Blood Pressure Monitoring
- Home Blood Pressure Monitoring
- Secondary Hypertension
- High-Risk Hypertension Populations
- Hypertension and CKD
Participants learn practical approaches to achieving blood pressure goals while minimizing adverse effects.
Insulin Resistance and Cardiometabolic Disease
Review of the growing relationship between metabolic dysfunction and cardiovascular disease.
Topics Include
- Insulin Resistance Pathophysiology
- Metabolic Syndrome
- Obesity and Cardiovascular Risk
- Prediabetes
- Type 2 Diabetes Mellitus
- Cardiometabolic Risk Assessment
The course emphasizes early identification and intervention strategies.
Lipid Management
A detailed review of current and emerging therapies for dyslipidemia.
Topics Include
- LDL Cholesterol Reduction
- Hypertriglyceridemia
- Familial Hypercholesterolemia
- Secondary Prevention
- Lipoprotein(a)
- Residual Cardiovascular Risk
Participants review guideline-based approaches and recent trial data.
Emerging Lipid Therapies
Topics Include
- PCSK9 Inhibitors
- Inclisiran
- Novel Lipid-Lowering Agents
- Future Lipoprotein Targets
Discussion focuses on integrating new therapies into clinical practice.
Atherosclerotic Cardiovascular Disease (ASCVD)
Contemporary prevention and management strategies.
Topics Include
- Coronary Artery Disease
- Cerebrovascular Disease
- Peripheral Artery Disease
- Risk Stratification
- Primary Prevention
- Secondary Prevention
Participants learn how to tailor treatment plans according to individual risk profiles.
Chronic Kidney Disease and Cardiovascular Risk
The conference explores the growing overlap between kidney disease and cardiovascular disease.
Topics Include
- CKD Risk Assessment
- Cardio-Renal Syndrome
- Blood Pressure Management in CKD
- Lipid Management in CKD
- Kidney-Protective Therapies
- Cardiovascular Outcomes in CKD
Novel Cardiovascular Prevention Therapies
Review of rapidly evolving therapeutic options.
Topics Include
- SGLT2 Inhibitors
- GLP-1 Receptor Agonists
- Combination Cardiometabolic Therapy
- Emerging Preventive Strategies
Special emphasis is placed on therapies that improve both cardiovascular and renal outcomes.
Cardiovascular Risk Screening
Topics Include
- Risk Assessment Tools
- Coronary Artery Calcium Scoring
- Biomarkers
- Screening Strategies
- Identification of High-Risk Individuals
Participants learn practical methods for improving early detection of cardiovascular disease.
Lifestyle and Non-Pharmacologic Prevention
Evidence-based lifestyle interventions remain a cornerstone of prevention.
Topics Include
- Nutrition and Dietary Approaches
- Weight Management
- Exercise Prescription
- Smoking Cessation
- Behavioral Interventions
Controversies in Cardiovascular Prevention
Expert discussions address ongoing debates in preventive medicine.
Topics Include
- Optimal Blood Pressure Targets
- Lipid Thresholds
- Screening Approaches
- Emerging Therapeutics
- Personalized Prevention Strategies
Educational Features
Evidence-Based Updates
Review of the most important recent cardiovascular prevention trials and guideline changes.
Practical Clinical Application
Focuses on strategies that clinicians can implement immediately in practice.
Cardiometabolic Perspective
Integrates cardiovascular, endocrine, metabolic, and renal medicine.
Expert Faculty
Presentations by leaders in preventive cardiology, endocrinology, hypertension, and lipid management.
Target Audience
Physicians
- Cardiologists
- Endocrinologists
- Internists
- Family Medicine Physicians
- Nephrologists
- Preventive Medicine Specialists
Advanced Practice Providers
- Nurse Practitioners
- Physician Assistants
Allied Health Professionals
- Pharmacists
- Nurses
- Diabetes Educators
Trainees
- Cardiology Fellows
- Endocrinology Fellows
- Internal Medicine Residents
Why This Course Stands Out
Comprehensive Cardiometabolic Focus
Integrates hypertension, diabetes, lipids, CKD, and ASCVD prevention into a single program.
Practical Prevention Strategies
Provides immediately applicable recommendations for reducing cardiovascular risk.
Emerging Therapies
Reviews the latest evidence supporting novel cardiometabolic treatments.
Multidisciplinary Approach
Relevant to both primary care and specialty practice.
Evidence-Based Education
Built around contemporary clinical guidelines and landmark research.
+ Topics:
Friday, September 19, 2025
- 8:15AM – 8:30AM Sign into Virtual Platform
- 8:30AM – 8:35AM Welcome & Introductions Debbie Cohen Stein, MD
- 8:35AM – 8:45AM What’s New in Hypertension Guidelines Jordana Cohen, MD
- 8:45AM – 8:55AM Peripartum Hypertension Management Monika Sanghavi, MD
- 8:55AM – 9:05AM Optimizing Antihypertensive Treatment Selection in Patients with CKD Matthew Denker, MD
- 9:05AM – 9:15AM Fibromuscular Dysplasia and Spontaneous Coronary Artery Dissection Jennifer Lewey, MD
- 9:15AM – 9:45AM Q&A Panel and Case Presentation with the Speakers Hanaro E Lee, CRNP RN (Moderator)
- 9:45AM – 9:50AM Break
- SESSION II: PREVENTIVE CARDIOLOGY – UNDERSTANDING RISK AND EVALUATION
- 9:50AM – 10:00AM How Do I Approach Triglycerides? dan E soffer, MD
- 10:00AM – 10:10AM Prediabetes: When to Treat and with What? Benjamin Cooperberg, MD
- 10:10AM – 10:20AM Advanced Lipid Testing/Lipoproteins and Discordance Douglas S Jacoby, MD
- 10:20AM – 10:50AM Q&A Panel and Case Presentation with the Speakers Emma MacAllister, CRNP
- 10:50AM – 10:55AM Break
- SESSION III: POTASSIUM AND HYPERTENSION
- 10:55AM – 11:05AM Potassium Management in the Setting of Blood Pressure Medications – When to Check and How to Titrate Accordingly John Demko, MD
- 11:05AM – 11:15AM Aldosterone Synthase Inhibitors – New Data and Considerations Debbie Cohen Stein, MD
- 11:15AM – 11:25AM Dietary Potassium and Potassium-based Salt-substitutes Rachel S Shulman, MSCE
- 11:25AM – 11:55AM Q&A Panel and Case Presentation with the Speakers Maria L Bonanni, CRNP (Moderator)
- 11:55AM – 12:00PM Break
- SESSION IV: NOVEL THERAPIES AND INDICATIONS
- 12:00PM – 12:10PM LPa-lowering Drugs Archna Bajaj, MD, MSCE
- 12:10PM – 12:20PM GLP1RA/Incretin Therapy: Updated Indications and Real-World Application Riya Patel, PharmD
- 12:20PM – 12:30PM Renal Denervation: Management and Setting Expectations Before and After Denervation Taisei Kobayashi, MD
- 12:30PM – 1:00PM Q&A Panel and Case Presentation with the Speakers Gayley B Webb, CRNP RN
Related products
Internal Medicine
Endocrine and Nutrition
The Brigham Board Review and Comprehensive Update in Endocrinology 2023
Cardiology
Nephrology / Urology
Internal Medicine
Harvard Updates in General Internal Medicine for Specialists 2022
Endocrine and Nutrition
Harvard Testosterone Therapy and Sexual Dysfunction February 2023
Endocrine and Nutrition
Comprehensive Care for Persons with Diabetes 2022: A Certificate Program
Endocrine and Nutrition
Harvard The Blackburn Course in Obesity Medicine Treating Obesity 2023